Painless Melanoma Detection Device

Inexpensive, Rapid, Painless Melanoma Detection by Skin Odors to Identify Malignancy Without Biopsy

This inexpensive detection of the presence of melanoma is real-time and uses vapor samples, enabling inexpensive and painless diagnoses. Melanoma is the deadliest form of skin cancer: Each year, an estimated 10,000 deaths occur from the disease, and 75,000 new cases are diagnosed. Detects biomarkers specific to melanoma  increasing accuracy of diagnosis. Operates in real-time, eliminating delay. Uses vapor or other sample, making diagnosis non-invasive and painless. These methods of detecting forms of cancer, such as melanoma, analyze the chemical compounds present in a sample of air surrounding potentially cancerous tissue, without a need for prior excision of the tissue.

UF Innovate at the University of Florida – Building business on innovation

Application

Portable, quick, non-invasive detection of biomarkers specific to melanoma

Advantages

  • Detects biomarkers specific to melanoma, increasing accuracy of diagnosis
  • Operates in real-time, eliminating delay
  • Uses vapor or other sample, making diagnosis non-invasive and painless

Technology

These methods of detecting forms of cancer, such as melanoma, analyze the chemical compounds present in a sample of air surrounding potentially cancerous tissue, without a need for prior excision of the tissue. These methods include the chemical analysis of the sample by mass spectrometry, liquid chromatography, gas chromatography, ion mobility spectrometry, or high-field asymmetric waveform ion mobility spectrometry. If a mole appears suspicious, a doctor can aspirate a sample of air over it. Analyzing the gas through ambient ionization and separation methods provides a spectrum of the gas specimen. In real-time, a direct analysis determines if the biomarkers for melanoma are present. This eliminates the need for the widely used “wait-and-watch” approach, as well as the need to biopsy every suspicious-looking mole, allowing more focused biopsy procedures.

 

For more information on this device or any of our other advancements in technology, please contact:

Mr. Ernest W. Letiziano, CEO
Corporate email : info@signetinternationalholdings.com
Direct email:  eletiziano@aol.com
Phone: +1.561.832.2000

Thank you for your interest in Signet.